D9610 Dental Code: Therapeutic Injection Billing

What D9610 covers

D9610 reports a single in-office administration of a therapeutic drug by injection.

Therapeutic means the drug treats a clinical problem: an antibiotic for an infection, a steroid for swelling, an anti-inflammatory, an antiemetic for nausea. It is not numbing tissue or sedating the patient.

Parenteral means the drug bypasses the digestive tract. Carrier policy reads that broadly, covering intramuscular, intravenous, subcutaneous, submucosal, intraosseous, and intranasal delivery. A pill the patient swallows is not parenteral.

The code reports one administration. A steroid injected to control post-extraction swelling is a single D9610 event.

The distinguishing axis: therapeutic, not anesthetic or sedative

D9610 is for a drug that treats something. The code excludes:

• Local anesthesia. Numbing the area for a procedure is D9210 or D9215.
• Sedation and general anesthesia. Minimal, moderate, and deep sedation each have their own codes, so an injected sedative is not a D9610 drug.
• Reversal agents. Drugs given to reverse sedation are part of the sedation episode, not a separate therapeutic administration.

The test is what the drug was for, not whether a drug was injected. Treating an infection, reducing swelling, or settling nausea fits D9610. Billing it for an anesthetic or sedative injection is the most common way this code goes wrong, and it gives a reviewer a clean reason to deny. Label D9610 as therapeutic, not anesthetic, in the PMS code table so the team uses it only for treatment drugs.

Single administration versus two or more: D9610 and D9612

D9612 is for two or more administrations of different medications at the same visit. The word different matters: D9612 counts distinct drugs, not injections.

• One therapeutic drug, given once: D9610.
• Two or more different therapeutic drugs at the same visit, such as a steroid and an antibiotic: D9612.

The same drug given more than once does not by itself move the claim to D9612. D9610 and D9612 describe the same kind of event at different volumes and are not reported together on the same date, so choose the one that matches what was given. Keep them as separate, clearly labeled entries in the PMS so the choice is deliberate.

The other neighbors: D9613 and D9630

D9613 reports infiltration of a sustained-release therapeutic drug, per quadrant. A depot or long-acting drug placed into a localized site and reported by quadrant is D9613, not a single systemic injection under D9610.

D9630 reports drugs or medicaments dispensed in the office for the patient to use at home. A drug injected in the operatory is D9610; medication handed to the patient for home use is D9630.

When to bill D9610

Bill D9610 when the dentist injects a single therapeutic drug in the office to treat a clinical condition. Typical situations:

• A steroid injection to control swelling after a surgical extraction.
• An antibiotic given by injection for an active infection during the visit.
• An antiemetic injected to manage nausea so the planned treatment can be completed.

Coverage reality

Coverage is plan-dependent and varies in three directions:

• Some plans don’t cover it at all, treating the drug administration as part of the procedure it supported.
• Some bundle it into a same-day surgical or operative procedure and deny D9610 as a separate line. When D9610 is on a claim with a surgical or operative procedure, a PMS claim edit or note that prompts the biller to confirm separate payability prevents a predictable denial.
• Some pay it with documentation. A narrative establishing the clinical reason for the drug (the infection, the swelling, the nausea) supports payment on plans that cover it conditionally.

The same drug may be paid separately by one plan, bundled by another, and excluded by a third. Verify the specific plan’s position before expecting D9610 to pay on its own.

Documentation that supports the claim

Therapeutic drug claims get questioned when the record doesn’t make the clinical case. Record at the time of service:

• The drug administered, by name.
• The dose and the route (intramuscular, intravenous, or subcutaneous).
• The clinical reason: the specific infection, swelling, nausea, or other condition being treated.
• That it was a single administration of one therapeutic drug, so the choice of D9610 over D9612 is clear from the record.

For plans that require a narrative, attach it to the claim line, not just the chart, so the clearinghouse sends it. Keep it specific to the patient; a generic line reused across therapeutic drug claims reads as templated when a reviewer sees a batch.